Carter's (CRI) Tops Q2 EPS by 6c

Carter's (NYSE: CRI) reported Q2 EPS of $0.72, $0.06 better than the analyst estimate of $0.66. Revenue for the quarter came in at $639 million versus the consensus estimate of $636.86 million.

Company revises fiscal 2016 sales forecast to growth of 5% - 6% (previously growth of 6% - 7%) and adjusted diluted EPS forecast to growth of approximately 10% (previously growth of 10% - 12%)

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
• UnitedHealth Group (UNH) Tops Q2 EPS by $1.53, Beats on Revenue; Offers FY26 EPS Guidance
• Main Street Capital posts preliminary Q2 2026 estimates with NAV gain